EI
RARE icon

Ellevest Inc’s Ultragenyx Pharmaceutical RARE Stock Holding History

Ellevest Inc’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11
Closed -$441 – 1322
2023
Q1 		$441 Hold
11
– – ﹤0.01% 1690
2022
Q4 		$510 Hold
11
– – ﹤0.01% 1613
2022
Q3 		$0 Buy
11
+1
+10% +$51 ﹤0.01% 1812
2022
Q2 		$1K Buy
+10
New +$615 ﹤0.01% 1307

Other funds holding RARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Ellevest Inc's RARE Position: Q2 2023 in Review

Ellevest Inc sold out of Ultragenyx Pharmaceutical (RARE) in Q2 2023, closing a stake of 11 shares — an estimated $441 sold.

Ellevest Inc first reported a position in RARE in Q2 2022 and held it in 4 quarters. The position peaked at $1K in Q2 2022. 242 funds tracked by Wall St. Rank hold RARE as of Q2 2023.

  • Ellevest Inc reported no remaining Ultragenyx Pharmaceutical position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 11 Ultragenyx Pharmaceutical shares in Q2 2023, an estimated $441.
  • Ellevest Inc first reported a position in Ultragenyx Pharmaceutical in Q2 2022 and held it in 4 quarters.
  • Ellevest Inc's Ultragenyx Pharmaceutical position peaked at $1K in Q2 2022.
  • 242 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.